2010 news that mentions MVI

Decade of vaccines begins with new models, funding challenges
December 16, 2010 – One of the most significant philanthropic initiatives of 2010 was the start of a "decade of vaccines" supported by the Gates Foundation with a $10 billion commitment to reach more children around the world dying of preventable diseases.
Seattle Times "The Business of Giving" Blog

First effective malaria vaccine?
December 14, 2010 – Scientists involved in the trial of a malaria vaccine in Kenya say they are optimistic that the world's first effective vaccine could be available in Africa by 2015. Stuart McDill reports.
Reuters TV

Malaria: New partnership aims to stop parasite in its tracks
December 14, 2010 – A new partnership is being launched to develop a malaria vaccine that would prevent parasites from entering the liver. Most of the symptoms of the disease develop after parasites have had time to replicate there.
Voice of America

N.J.'s Merck joins collaboration to develop new malaria vaccine
December 14, 2010 – Merck said it is planning to collaborate with an international non-profit organization and New York University’s Langone Medical Center to develop a vaccine capable of preventing the malaria parasite from entering the human liver.
Star-Ledger

Special report - The cost of a malaria-free world
December 14, 2010 – LONDON (Reuters) - Joe Cohen, a scientist tantalisingly close to delivering the world's first malaria vaccine, is on the stump.
After 23 years of painstaking laboratory work and a programme of major trials in seven countries, the 67-year-old biologist says the clinical case for the vaccine is almost proved.
Reuters

Could malaria vaccine “sit on the shelf”?
December 13, 2010 – By the year 2015, the first vaccine against malaria could be ready for use on a wide scale. But concerns have been expressed that inadequate planning could prevent it reaching those who are most in need of protection against the disease.
TropIKA.net

Malaria vaccine: Inside look at the first human trial
November 16, 2010 – The first clinical trial for a vaccine against the most widespread strain of malaria, Plasmodium vivax, is now under way at the Walter Reed Army Institute for Research (WRAIR), near Washington DC.
BBC News

Halting the world's most lethal parasite: Immunizing mosquitoes and other 'crazy' anti-malaria ideas
November 3, 2010 – A new malaria vaccine, a plan to immunize mosquitoes and other "crazy" ideas have brightened prospects for vanquishing this killer.
Scientific American Magazine

Paludisme : le premier vaccin en 2012?
October 1, 2010 – La protéine RTS,S du parasite responsable du paludisme, Plasmodium falciparum, a donné son nom à un candidat vaccin qui paraît aujourd’hui, le plus avancé des candidats en lice.
Destination Sante (France)

Conference highlights progress towards malaria vaccine
September 28, 2010 – Scientists have made huge strides in the race to produce a malaria vaccine but their efforts to save hundreds of thousands of lives could be slowed by the global economic crisis, officials told a conference Tuesday.
Agence France Presse

Major breakthrough in war against malaria
September 24, 2010 – Researchers at the Walter and Eliza Hall Institute (WEHI) have discovered a new pathway through which malaria is able to infect the body, opening up the possibility of new vaccines to combat the virus.
Australian Life Scientist

Malaria vaccine on the horizon
September 10, 2010 – Scientists in African countries, including Tanzania, have begun trials of a malaria vaccine which, if successful, could save millions of lives on the continent and around the world.
Daily News (Tanzania)

Gates Foundation shakes up science with goal to end malaria
September 9, 2010 – "Over the past five years, we have probably learned more about malaria than in any other time period in history," says researcher Stefan Kappe, holding a container of mosquitoes at Seattle BioMed, a nonprofit lab focused on diseases of the developing world.
Seattle Times

Hope as malaria vaccine nears home
August 19, 2010 – Malaria, the disease that causes thousands of death, majority of whom are pregnant women and children below the age of six may soon subside, thanks to the initiative to engage Uganda in the process of implementing a decision to use the malaria vaccine once it is out for use.
Daily Monitor (Uganda)

MVI receives high marks in key areas of its work
August 12, 2010 – A recent evaluation of the operations and research portfolio of the PATH Malaria Vaccine Initiative assesses as "outstanding" MVI's engagement with industry and its use of milestones to measure progress. The report was conducted by FasterCures' Philanthropy Advisory Service (PAS), which works to promote informed investment decisions among philanthropists. Published in early 2010, the report describes as "strong" MVI's work in a range of other areas, including scientific advancement and vaccine access and delivery. The report is part of a series that looks at specific diseases and assesses the nonprofit institutions doing medical research on them. To access the report, PAS asks that interested parties visit the site and register to download the report (a simple and free process). You may also contact MVI for a copy.
FasterCures

Can malaria be beaten?
August 5, 2010 – When I see a packet of malaria pills I think of that famous Clint Eastwood line from Dirty Harry, delivered as he pointed his .44 magnum at a bank robber and neither of them could remember how many shots he had fired, or whether there was still one left in the chamber. "The question you have got to ask yourself is: do I feel lucky? Well, do ya, punk?"
The Independent (UK)

De nouveaux leaders et de nouveaux outils peuvent transformer la lutte contre le paludisme
July 28, 2010 – On se souviendra du sommet de l’Union Africaine de cette semaine pour son courage. Quelques semaines seulement après une attaque terroriste dévastatrice à Kampala, l’Union Africaine s’est malgré tout réunie dans la capitale de l’Ouganda pour débattre de nos priorités les plus urgentes.
Sud Quotidien (Senegal)

Weighty goals for African Union summit
July 28, 2010 – The annual African Union summit came to a close on Tuesday after multilateral talks in the Ugandan capital of Kampala that covered everything from health to terrorism. The meeting came two weeks after terrorist bombings in the city by al-Shabaab, a Somali insurgency that itself was the subject of much discussion at the summit.
The Atlantic Wire

New leaders, new tools can transform fight against malaria
July 26, 2010 – This week’s African Union meeting will be remembered for its courage. Just a few weeks after a devastating terrorist attack in Kampala, the African Union is still convening in Uganda’s capital city to tackle our most urgent priorities.
Citizen (Tanzania)

Feature: A world without malaria
July 13, 2010 – Australian researchers have made exciting progress towards a malaria vaccine, and the past year has seen major research developments that raise real hope that malaria can even be eradicated.
Australian Life Scientist

The 'do unto others' malaria vaccine
May 14, 2010 – Once neglected, research on transmission-blocking vaccines (TBVs) for malaria is gaining new prominence. It used to sound like a far-out idea: a malaria vaccine that would use humans to generate antibodies and deliver them to mosquitoes, with the aim of preventing the insects from spreading the disease. Until recently, such TBVs had received scant attention.
Science

That was then but this is now: malaria research in the time of an eradication agenda
May 14, 2010 – The global research community must take up the challenge to work toward the eradication of malaria. In the past, malaria research has focused on drugs and vaccines that target the blood stage of infection, and mainly on the most deadly species, Plasmodium falciparum, all of which is justified by the need to prevent and treat the disease. This work remains critically important today.
Science

Science: as challenges change, so does science
May 14, 2010 – Although nobody believes that it is possible in the next 10, 20, or even 30 years, the call to eradicate malaria, combined with the plummeting disease burden, are already reshaping the scientific agenda.
Science

Bill Gates takes on global challenges
April 30, 2010 – Entrepreneur turned philanthropist Bill Gates received the Bower Award for Business Leadership on Thursday from the Franklin Institute. Earlier in the day, he spent 30 minutes answering questions from an Inquirer reporter on such diverse issues as global health, nuclear energy and electronic privacy.
Philadelphia Inquirer

Lipoxen receives positive results for ImuXen candidates for influenza and malaria
April 28, 2010 – Lipoxen (AIM: LPX) has received positive results for two of its ImuXen proprietary candidates, one devolped as a novel influenza vaccine and the other as a malaria vaccine. Lipoxen's proprietary ImuXen technology uses lipids, natural substances found in the human body, to entrap active ingredients—like antigens—to ensure direct delivery into the appropriate cells of the immune system.
ProactiveInvestors.co.uk

Closer than ever
April 27, 2010 – Dr. Lusingu is a Principal Investigator with the Joint Malaria Programme, a collaboration between National Institute for Medical Research of Tanzania, the Kilimanjaro Christian Medical College, the London School of Hygiene and Tropical Medicine and the University of Copenhagen
ONE Blog

New malaria vaccine promising
April 27, 2010 – The new malaria vaccine developed by British researchers yielded success in its second round of testing. Now, the world watches and waits for results of the latest round. As researchers pioneer the testing of a new vaccine that could protect against malaria, health workers and development practitioners working in Africa are optimistic that the illness will soon meet the same demise as polio.
Soschildrensvillages.com

Kenya closer to vaccine against killer disease
April 26, 2010 – Kenya could have its first malaria vaccine by 2015, according to researchers at Kenya Medical Research Institute and the Centres of Disease Control. The third phase of RTS,S the world's most clinically advanced malaria vaccine candidate began last year.
Daily Nation

The day after World Malaria Day
April 26, 2010 – Nearly three years ago, Bill and Melinda Gates called upon the world to eradicate malaria (Seattle PI). That upset a lot of people, many of them specialists in malaria, largely because it was regarded as violating Voltaire's warning against seeking perfection at the expense of the good.
A Page from Tom Paulson

On the front line against malaria: Army medical researchers in Kenya mark World Malaria Day 2010
April 26, 2010 – Hundreds of local people gathered Sunday at Kit Mikayi primary school to mark World Malaria Day 2010 with educational skits, songs and dance. Among them was Lt. Col. Maria Bovill, director of US Army Medical Research Unit-Kenya's Kombewa clinic—where research into the world's first malaria vaccine is underway.
AllAfrica.com

Three conditions needed for true "decade of vaccines"
April 23, 2010 – Recently, Bill Gates injected new energy and resources into the immunization field with an unprecedented pledge of US$10 billion through 2020 for vaccine development and delivery. It was a great start to the new decade. From my vantage point at one of the world’s largest vaccine companies, I can identify three conditions that will be needed for the next ten years to live up to the designation of the "decade of vaccines."
ONE Blog

Africa: World must retain focus on anti-malaria fight, says expert
April 23, 2010 – Despite recent achievements in fighting malaria, the international community must not become complacent or distracted, says Dr. Steven Phillips, medical director of global issues and projects for ExxonMobil. Phillips, who also serves on the board of Malaria No More, spoke with allAfrica.com ahead of World Malaria Day, reflecting on progress in the fight against the disease.
AllAfrica.com

Vaccine development: Hopeful results lead to first large-scale trial
April 22, 2010 – Over the past year, 9,000 babies and young children in seven African countries have received a shot of the first malaria vaccine to undergo a large-scale clinical trial. Eventually as many as 16,000 children will receive the so-called RTS,S vaccine.
Financial Times

Guest column: The numbers tell a promising story for World Malaria Day 2010
April 22, 2010 – As a businessman, I track statistics and focus intensely on the bottom line. For World Malaria Day 2010, April 25, the numbers tell a promising story.
Financial Times

Disease development: New strain develops ways round immunity
April 22, 2010 – Most malaria research and writing focuses on Plasmodium falciparum, the most deadly of the four species of parasite that cause human malaria.
Financial Times

World Malaria Day 2010: Africans advance quest for a malaria vaccine
April 20, 2010 – On World Malaria Day 2010, the international community marks a historic milestone in the fight against malaria. This past year, we launched a Phase 3 efficacy trial of the world's most advanced malaria vaccine candidate in 11 research centers spanning seven African countries.
Modern Ghana

Dernière ligne droite pour un vaccin antipaludisme
March 17, 2010 – On l'espère depuis des décennies, il existera peut-être dans quelques années. Pour la première fois dans l'histoire de la médecine, un candidat vaccin contre le paludisme est entré, depuis presque un an, en phase 3 d'essais cliniques en Afrique.
Le Monde

Questions as mileposts of progress
February 4, 2010 – Recently Melinda Moree (newly appointed CEO of BioVentures for Global Health) and I attended an interesting dinner of global health experts in New York... Melinda remarked on the progress with malaria vaccines where the questions now are all about who will pay for it, and how will we roll the vaccine out in affected countries.
Huffington Post

Gates promises US$10 billion for vaccine push
February 1, 2010 – The Bill & Melinda Gates Foundation has pledged to spend more than US$10 billion on vaccine development and deployment in the next decade.
SciDev.net

Malaria vaccine is in the works
February 1, 2010 – A vaccine against malaria to save the lives of hundreds of thousands of children a year could be available as early as 2012, according to African scientists who are testing the new drug.
GlobalPost

Maps, mosquitoes, and malaria
January 25, 2010 – Cameron Taylor, a UNC undergrad, went to Lilongwe in the summer of 2008 to help lay the groundwork for a Phase 3 trial of the most promising malaria vaccine to date. Like most other sub-Saharan countries, Malawi is hard-hit by malaria, and the vaccine trial is gaining popularity among Malawians.
Endeavors Magazine (University of North Carolina at Chapel Hill)

GSK gives price pledge on malaria vaccine
January 21, 2010 – GlaxoSmithKline, the UK-based pharmaceutical group, pledged to price its experimental malaria vaccine at just above cost, in an effort to ensure funding for its widespread use at a time of growing nervousness over donors’ willingness to support global health projects.
Financial Times

Les gorilles porteurs du parasite du paludisme
January 19, 2010 – Le parasite du paludisme le plus meurtrier en Afrique a été découvert chez des gorilles, alors que l’on pensait qu’il n’infectait que les humains.
Sciences-et-Avenir.com (France)

New malaria vaccine initiative aims to stunt parasite within mosquitoes
January 18, 2010 – A new vaccine initiative has been launched to try to prevent the malaria parasite from developing inside mosquitoes.
Voice of America

A new strategy in the war on malaria
January 18, 2010 – A nonprofit in Bethesda is developing a new weapon in the global vaccine arsenal against malaria.
Maryland Gazette

Hopes for a new kind of malaria vaccine
January 15, 2010 – Malaria was eradicated in the U.S. by 1951, so Americans can be forgiven for not giving the disease much thought.
Time Magazine

Top 2009 Global Pandemic Happenings: Part 2
January 2, 2010 – Number 2, An Effective Malaria Vaccine Coming Soon? In 2009, phase 3 human clinical trials began with the most promising malaria vaccine to date.
The Faster Times